Arrhythmia Research Group

02/20/2026

Advancing the future of heart rhythm care—together. ❤️

Proud to celebrate each milestone as we continue progressing arrhythmia research one study at a time, bringing innovative treatments and better outcomes to patients.

02/05/2026

February is Heart Health Month, and under the leadership of Dr. Devi Nair, we are creating "A New Era For The Heart"! 🫀✨

In the latest issue of Jonesboro Occasions, Dr. Devi Nair discusses the driving forces behind the improvements in cardiovascular care and her mission alongside ARG to provide leading-edge cardiovascular care in the Jonesboro area.



Read more at jonesborooccasions.com!

01/29/2026

AF Symposium 2026 kicks off next week in Boston, and our very own PI, Dr. Devi Nair, will be presenting in a Spotlight Session and will be involved in multiple cutting-edge sessions exploring the future of atrial fibrillation treatment — including advanced pulsed field ablation technologies, AI-assisted mapping, left atrial appendage closure, and next-generation catheter systems.🫀✨

We look forward to an exciting few days of insight, collaboration, and innovation in the field of electrophysiology!

For more information, visit afsymposium.com

01/22/2026

We're marking more milestones in 2026!🫀✨

This week, Principal Investigator and our team, alongside , Cardiac and Vascular, and Dr. Vivek Reddy, marked the First U.S. case day for the HORIZON 360 paroxysmal AF study and some of its first U.S. enrollments!🤍✨

Thank you to our collaborators for your dedication and insights as we utilized the Sphere 360 PFA system with mapping, featuring an intuitive workflow, streamlined map-and-ablate strategy, and zero fluoroscopy. With your collaboration and efforts, we are working to advance PFA platforms and atrial fibrillation care!👏🤝✨

01/15/2026

Marking Major Milestones Right Here At ARG!🫀✨

Alongside the St. Bernards Heart & Vascular Electrophysiology Heart Rhythm team, we have successfully completed some of the first cases in the United States using Abbott's VOLT technology to treat atrial fibrillation, following shortly after its recent FDA approval.👏

This technology is designed to assist doctors in treating abnormal heart rhythms with precision and safety while keeping procedures efficient and focused on the patient.

Thank you to the St. Bernards EP Lab & Abbott Cardiovascular's clinical support team -- your teamwork and expertise made this a success!

We're grateful and proud to help expand patient access to innovative heart rhythm care for patients in the region! Here's to progress.🤝🤍 Devi Gopinath Nair

Our electrophysiology heart rhythm team has successfully completed some of the first cases in the country using Abbott’s VOLT technology for treating atrial fibrillation, following its recent FDA approval. This marks another step forward in bringing advanced heart care close to home for our community.

This new technology is designed to help doctors treat abnormal heart rhythms more precisely and safely, while supporting efficient procedures and a strong focus on patient care.

Congrats to Dr. Devi Nair and team! We are grateful to continue expanding access to innovative heart rhythm care for the patients and families we serve.

01/06/2026

🔍 At Arrhythmia Research Group, we’re committed to precision and excellence in every detail. 🫀

We’re here to advance research and deliver the best possible outcomes.

12/31/2025

2025 has been a milestone year for Arrhythmia Research Group (ARG), and we want to take a moment to thank everyone who helped make it possible. From ablation trials, stroke prevention trials, and Cardiac Rhythm Management Device trials including global first enrollments, to leading conversations at major events like Rhythm Interventions Online, we’ve continued to drive innovation in the world of electrophysiology and rhythm management.
This year, we strengthened our commitment to advancing cardiac care, contributing valuable research, and pushing the boundaries of medical technology to better serve patients. Our team, along with our incredible collaborators, made these achievements a reality. Thank you for being part of this journey! We are excited to continue making strides in 2026 and beyond!👏🤍✨

12/23/2025

💡 At Arrhythmia Research Group, collaboration is key to advancing the future of cardiovascular care. 💪

Together, we’re working to make a difference in the lives of those we serve.

11/07/2025

We're Leading the Way At ARG! We are proud to share that our team, alongside St. Bernards Heart & Vascular EP Lab, has performed the first WiSE® System implant as part of the WiSE-UP Study under the leadership of Dr. Gopinath Nair ! We are also proud to mark the first global patient enrollments in the WiSE-UP Post-Approval Study! These achievements mark an incredible milestone in advancing cardiac resynchronization therapy (CRT).

Thank you to our remarkable team for your dedication to improving patient care & to EBR Systems, Inc. for your collaborative and innovative efforts that help push the boundaries of electrophysiology! Here's to innovation and advancing care.🫀✨



🔗 ASX Announcement: https://lnkd.in/gT_9aqr6

11/05/2025

Last week, ARG Director and CEO Dr. Devi Gopinath Nair had the privilege of attending LAHRS 2025 in Buenos Aires.

This meeting was a powerful reminder of how essential global collaboration is to advancing heart rhythm care — from sharing research to harmonizing best practices across regions.

Our sincere thanks to Dr. López Cabanillas Néstor, Dr. Ulises Rojel-Metz, Dr. JC Zerpa, and Dr. Eliany Mejía for the warm welcome and for your inspiring leadership of the Latin American Heart Rhythm Society. We’re grateful to be part of this international community working to improve outcomes for patients with arrhythmias. 💙